Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Image

Neoadjuvant durvalumab plus chemotherapy in resectable or borderline resectable non-small-cell lung cancer: the phase 2 MDT-BRIDGE trial

Journal content Created on 26 Oct 2026 Nature Medicine

Published in

Nature Medicine, Nature Publishing Group

Content

There is no additional content. Please click on the source link to view more information.

Jonathan Spicer

Advertisement

Stats

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 16
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement